JDPRX
Price
$17.17
Change
-$0.10 (-0.58%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

JDPRX vs VMVAX

Header iconJDPRX vs VMVAX Comparison
Open Charts JDPRX vs VMVAXBanner chart's image
Janus Henderson Mid Cap Value R
Price$17.17
Change-$0.10 (-0.58%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JDPRX vs VMVAX Comparison Chart
Loading...
VS
JDPRX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDPRX is a StrongBuy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. JDPRX (2.13B). VMVAX pays higher dividends than JDPRX: VMVAX (2.14) vs JDPRX (0.49). JDPRX was incepted earlier than VMVAX: JDPRX (15 years) vs VMVAX (13 years). JDPRX is a more actively managed with annual turnover of: 54.00 vs. VMVAX (22.00). JDPRX has a lower initial minimum investment than VMVAX: JDPRX (2500) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. JDPRX (16.95). VMVAX return over 5 years is better than : 48.82 vs. JDPRX (13.69).
JDPRXVMVAXJDPRX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years13 years-
Gain YTD14.90414.946100%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets2.13B30.5B7%
Annual Yield % from dividends0.492.1423%
Returns for 1 year16.9525.3567%
Returns for 3 years1.6920.718%
Returns for 5 years13.6948.8228%
Returns for 10 years-25.04100.88-25%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio